IOVS Brain
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cubitt, C. L.
Right arrow Articles by Oakes, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cubitt, C. L.
Right arrow Articles by Oakes, J. E.
(Investigative Ophthalmology and Visual Science. 2001;42:701-704.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Synthesis of Type II Interleukin-1 Receptors by Human Corneal Epithelial Cells but not by Keratocytes

Christopher L. Cubitt, Robert N. Lausch and John E. Oakes

From the Department of Microbiology and Immunology, University of South Alabama, College of Medicine, Mobile, Alabama.

PURPOSE. The purpose of this study was to determine whether human corneal epithelial cells and keratocytes synthesize both the soluble and membrane forms of the type II IL-1 receptor (IL-1RII).

METHODS. Primary cell cultures of human corneal epithelial cells and keratocytes were established from human corneas. RT-PCR was used to analyze cell cultures for expression of IL-1RII mRNA. The capacity of corneal cells to synthesize membrane-bound IL-1RII was determined by immunofluorescence microscopy, whereas ELISA was used to quantitate synthesis of soluble IL-1RII after IL-1{alpha} and TNF-{alpha} stimulation.

RESULTS. Corneal epithelial cells expressed IL-1RII mRNA. The cells also stained positive for membrane-bound IL-1RII, and media harvested from epithelial cell cultures contained up to 50 pg/ml of soluble IL-1RII. Both IL-1{alpha} and TNF-{alpha} significantly enhanced the amounts of soluble IL-1RII released from epithelial cell surfaces. In contrast to epithelial cells, corneal keratocytes did not express IL-1RII mRNA. Membrane-bound IL-1RII was not detected on keratocytes, nor was soluble IL-1RII detected in culture media harvested from these cells.

CONCLUSIONS. Human corneal epithelial cells but not corneal keratocytes synthesize both membrane and soluble forms of IL-1RII. Because both forms of IL-1RII can function as IL-1{alpha} antagonists, the results suggest that human corneal epithelial cells but not corneal keratocytes have evolved the capacity to dampen IL-1{alpha} responses through the production of IL-1RII.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. T. Lee, J. G. Lee, M. Na, and E. P. Kay
FGF-2 Induced by Interleukin-1{beta} through the Action of Phosphatidylinositol 3-Kinase Mediates Endothelial Mesenchymal Transformation in Corneal Endothelial Cells
J. Biol. Chem., July 30, 2004; 279(31): 32325 - 32332.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. B. Mahajan, C. Wei, and P. J. McDonnell III
Microarray Analysis of Corneal Fibroblast Gene Expression after Interleukin-1 Treatment
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2143 - 2151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology